Markku Kurkinen on Shrunken FDA Advisory Committee Is Unanimous: Leqembi Works
COMMENT Lecanemab did not work for women, which is bad news because there are twice as many women as men with AD. Lecanemab did not work for APOE4 carriers, which is bad news for AD patients, 60–75 percent of whom have one or two APOE4 genes. Remarkably, for some